Remove Arcturus Remove Blogging Remove Platform Remove Startup
article thumbnail

Litigation in Israel and U.S. Mires RNA Drug Developer Arcturus

Xconomy

In the five years since it was founded, San Diego-based Arcturus Therapeutics (NASDAQ: ARCT ) says it has built a versatile platform for developing a variety of RNA-based medicines. Dueling lawsuits between the ousted CEO and the board could consume. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.